Financial Data and Key Metrics Changes - The company reported organic sales growth of approximately 1.2% year-to-date, with expectations for Q4 to improve slightly [52][83] - Gross profit margin was down year-over-year, primarily due to raw materials inflation and lower volumes impacting fixed cost leverage [62][63] - The company maintained its EPS guidance despite challenges, indicating resilience in its business model [83][84] Business Line Data and Key Metrics Changes - The Hill's business showed organic growth of 2.5% excluding private label, with strong performance in therapeutic diets [74] - Latin America experienced organic growth of 17%, although impacted by a formula change in Colgate Total, which had a negative volume impact of 150 basis points [25][26] - The Colgate brand in China saw mid-single-digit growth driven by e-commerce and innovation, while Dali faced challenges in premium e-commerce [17] Market Data and Key Metrics Changes - North America showed slight improvement in performance, particularly excluding skin health, but overall consumer sentiment remains weak [15][16] - In Europe, pricing remained positive, but the company anticipates challenges in maintaining this trend due to prolonged inflation [48][49] - Latin America showed mixed results, with Mexico and Brazil performing well, while Colombia and Central America faced economic challenges [17][25] Company Strategy and Development Direction - The company is focused on executing its 2030 strategy, which aims to accelerate growth and adapt to a complex operating environment [4][5] - Investments in AI and innovation are central to the company's strategy, aimed at enhancing productivity and consumer engagement [70][68] - The Strategic Growth and Productivity Program is designed to fund incremental investments and deliver savings to drive dollar-based earnings growth [8][85] Management's Comments on Operating Environment and Future Outlook - Management acknowledged ongoing consumer uncertainty and market volatility, but expressed confidence in the company's ability to adapt and grow [3][14] - The company expects sluggishness in the market to continue in the short term, but is taking steps to stimulate growth [15][16] - Long-term outlook remains positive, with expectations for improved performance in key markets like India following recent tax changes [37] Other Important Information - The company is proactively addressing consumer complaints related to Colgate Total and has adjusted formulas in collaboration with health authorities [26] - The exit from the private label business is expected to positively impact growth moving into 2026 [75] - The company is leveraging AI to enhance marketing strategies and improve operational efficiency [68][70] Q&A Session Summary Question: Expectations for category softness into 2026 - Management indicated that while category softness is expected to linger, they are implementing changes to stimulate growth [14][15] Question: Impact of Colgate Total formula change in Latin America - The formula change had a negative impact on volume, but market shares are beginning to recover following adjustments [25][26] Question: GST tax change impact in India - The GST reduction is expected to benefit consumption in the long term, with plans in place to address sluggishness in urban areas [37] Question: Challenges in the U.S. drugstore channel - Management is re-engaging with drugstore channels to drive traffic and improve category dynamics [43] Question: Pricing environment in Europe - The company is optimistic about maintaining positive pricing, although challenges remain due to inflation [48][49] Question: EPS guidance amidst gross margin decline - The company expects to maintain EPS guidance through strategic changes and operational efficiencies [83][84]

Core Insights - Colgate-Palmolive reported quarterly earnings of $0.91 per share, exceeding the Zacks Consensus Estimate of $0.89 per share, with an earnings surprise of +2.25% [1] - The company posted revenues of $5.13 billion for the quarter ended September 2025, slightly missing the Zacks Consensus Estimate by 0.07%, but showing a year-over-year increase from $5.03 billion [2] - The stock has underperformed the market, losing about 15.8% year-to-date compared to the S&P 500's gain of 16% [3] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $0.94, with expected revenues of $5.15 billion, and for the current fiscal year, the EPS estimate is $3.67 on revenues of $20.31 billion [7] - The estimate revisions trend for Colgate-Palmolive was unfavorable prior to the earnings release, resulting in a Zacks Rank 4 (Sell) for the stock, indicating expected underperformance in the near future [6] Industry Context - The Consumer Products - Staples industry, to which Colgate-Palmolive belongs, is currently ranked in the bottom 17% of over 250 Zacks industries, suggesting potential challenges ahead [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which could impact investor sentiment [5]

Financial Performance & Guidance - Net sales increased by 20%[18] - Organic sales increased by 04%, led by oral care, including a 08% negative impact from lower private label pet sales[18] - The company returned $21 billion to shareholders year to date[31] - Net sales growth is expected to be up low single digits, including a flat to low-single-digit negative impact from foreign exchange[24] - Organic sales growth is now expected to be 1% to 2%, roughly in line with year-to-date organic sales growth of 12%, including an approximately 70 basis point impact from exit from private label pet sales[25] - The company expects approximately $75 million in tariff costs for 2025[26] Strategic Initiatives - The company announced a new three-year productivity program to drive future top and bottom line growth and support the Company's 2030 strategy[20] - The Strategic Growth and Productivity Program is projected to result in cumulative pre-tax charges totaling between $200 and $300 million over the course of the three-year program[21] - Colgate Bright Smiles, Bright Futures achieved a new milestone - reaching approximately 2 billion children and their families worldwide since 1991[18] Market Share - Global toothpaste market share was up 10 basis points on a volume basis year to date[18] - Global manual toothbrush market share was up 50 basis points on a volume basis year to date[18]

Core Insights - Colgate-Palmolive Co. reported a slight increase in third-quarter sales, driven by higher pricing that compensated for a decline in product volumes [1] Sales Performance - The company experienced a rise in sales due to increased pricing strategies, which helped mitigate the impact of reduced product volumes [1] Product Volumes - There was a noted drop in product volumes, indicating potential challenges in demand or market competition [1]

Core Viewpoint - Colgate-Palmolive has reduced its annual sales forecast, indicating that rising economic uncertainty is affecting consumer spending on higher-priced essential items [1] Company Summary - Colgate-Palmolive is facing challenges in maintaining sales due to economic conditions that are leading consumers to be more cautious with their spending [1] - The company’s adjustment in sales forecast reflects a broader trend in the market where consumers are prioritizing lower-cost alternatives [1] Industry Summary - The consumer goods industry, particularly in essential products, is experiencing a shift as economic uncertainty influences purchasing behavior [1] - There is a growing trend of consumers opting for more affordable options, which may impact sales for companies offering premium products [1]

Financial Performance - Net sales for Q3 2025 increased by 2.0% to $5,131 million compared to $5,033 million in Q3 2024[2] - GAAP EPS rose by 1% to $0.91, while Base Business EPS remained flat at $0.91[3] - Organic sales growth was 0.4%, impacted by a 0.8% decline from exiting the private label pet sales business[3] - Total operating profit for Q3 2025 was $1,059 million, a decrease of 1% compared to Q3 2024[11] - Net income attributable to Colgate-Palmolive Company for Q3 2025 was $735 million, compared to $737 million in Q3 2024[25] - Free cash flow before dividends for the nine months ended September 30, 2025, was $2,358 million, down from $2,461 million in the same period of 2024[31] - Reported GAAP net income for 2025 was $2,951 million, with a diluted earnings per share of $2.67 and an effective tax rate of 23.2%[53] - Non-GAAP net income for 2025 was $3,027 million, with a diluted earnings per share of $2.74, maintaining the same effective tax rate of 23.2%[53] - Reported GAAP net income for 2024 was $2,963 million, with a diluted earnings per share of $2.61 and an effective tax rate of 23.4%[53] - Non-GAAP net income for 2024 was $3,040 million, with a diluted earnings per share of $2.69, reflecting a slight decrease in effective tax rate to 23.1%[53] Profitability Metrics - The gross profit margin decreased by 170 basis points to 59.4% on a GAAP basis[3] - Gross profit margin decreased to 59.4% in Q3 2025 from 61.1% in Q3 2024[25] - Operating profit for Q3 2025 was $1,059 million, slightly down from $1,065 million in Q3 2024, resulting in an operating profit margin of 20.6%[25] - Gross profit for Q3 2025 was $3,049 million, down from $3,074 million in Q3 2024, reflecting a gross profit margin decrease from 61.1% to 59.4%[46] - For the nine months ended September 30, 2025, gross profit was $9,105 million, compared to $9,179 million in the same period of 2024, with a gross profit margin of 60.1%[51] Sales Performance by Region - North America experienced a net sales decline of 0.4%, while Europe saw an increase of 7.6%[9] - North America experienced a sales decline of 0.4%, with organic sales down 0.5% and volume also down 0.5%[38] - Europe showed strong performance with a sales increase of 7.6%, organic sales growth of 1.2%, and volume growth of 0.8%[38] - Africa/Eurasia reported a sales increase of 6.8%, with organic sales growth of 6.2% and volume decline of 1.1%[38] - Emerging Markets reported a sales increase of 1.6%, with organic sales growth of 1.0% despite a volume decline of 2.6%[38] Strategic Initiatives - The company is implementing a new 2030 strategy aimed at accelerating growth and enhancing innovation capabilities[5] - The Strategic Growth and Productivity Program is designed to support organizational structure and achieve consistent earnings per share growth over the long term[5] - The acquisition of the Prime100 pet food business positively impacted reported volume by 0.4% for Total Company[39] Expenses and Costs - Advertising expenses for Q3 2025 were $674 million, down from $694 million in Q3 2024[25] - Selling, general and administrative expenses for Q3 2025 were $1,971 million, slightly down from $1,979 million in Q3 2024[46] - The company incurred $65 million in ERISA litigation costs, which did not affect the diluted earnings per share[53] - Acquisition-related costs amounted to $9 million, contributing minimally to the overall financial performance[53] Taxation - The effective tax rate for Q3 2025 was 22.8%, up from 21.3% in Q3 2024[25] - The effective tax rate for the company was calculated based on applicable tax laws and statutory rates in relevant jurisdictions[54] - The impact of non-GAAP items on the effective tax rate reflects the difference calculated with and without these adjustments[54]

Core Insights - Colgate-Palmolive reported an increase in sales during the third quarter, driven by higher prices that compensated for a decline in sales volumes [1] Sales Performance - The company experienced a rise in sales, indicating resilience in pricing strategies despite volume challenges [1]

Colgate-Palmolive. reported third-quarter earnings above Wall Street’s consensus, driven by resilient consumer demand in Latin American https://t.co/A8Us5YSaXv ...

Group 1 - The article does not provide any relevant content regarding company or industry insights [1]

Earnings Report - Colgate-Palmolive Company is set to release its third-quarter earnings results on October 31, with analysts expecting earnings of 89 cents per share, a decrease from 91 cents per share in the same period last year [1] - The consensus estimate for quarterly revenue is $5.13 billion, up from $5.03 billion a year earlier [1] Previous Quarter Performance - In the second quarter, Colgate-Palmolive reported adjusted earnings per share of 92 cents, surpassing the analyst consensus estimate of 89 cents [2] - Following the second-quarter report, Colgate-Palmolive shares increased by 1% to close at $76.51 [2] Analyst Ratings and Price Targets - Raymond James analyst Olivia Tong maintained an Outperform rating but reduced the price target from $105 to $95 [4] - JP Morgan analyst Andrea Teixeira kept an Overweight rating while lowering the price target from $95 to $88 [4] - Piper Sandler analyst Michael Lavery assigned a Neutral rating with a price target of $84 [4] - Barclays analyst Lauren Lieberman maintained an Equal-Weight rating and cut the price target from $87 to $82 [4] - Morgan Stanley analyst Dara Mohsenian upheld an Overweight rating and decreased the price target from $104 to $96 [4]